Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA262841
Max Phase: Preclinical
Molecular Formula: C53H75BrN2O14
Molecular Weight: 1044.09
Molecule Type: Small molecule
Associated Items:
ID: ALA262841
Max Phase: Preclinical
Molecular Formula: C53H75BrN2O14
Molecular Weight: 1044.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C[C@@H]2C[C@@H]3C[C@@H](O)C[C@@H](O3)c3coc(n3)/C=C/C[C@H]3O[C@@H](/C(C)=C/[C@H](CO)NC(=O)C[C@]4(O)C[C@H](OC)C[C@H]([C@H](O)/C=C(C)/C=C/[C@@H](C/C=C/Br)OC)O4)[C@H](C)[C@@H](OC(=O)/C=C\C[C@@H](C1)O2)[C@H]3C
Standard InChI: InChI=1S/C53H75BrN2O14/c1-31(16-17-38(63-6)12-10-18-54)21-44(59)47-26-42(64-7)27-53(62,70-47)28-48(60)55-36(29-57)22-33(3)51-35(5)52-34(4)45(68-51)13-9-14-49-56-43(30-65-49)46-24-37(58)23-41(67-46)25-40-20-32(2)19-39(66-40)11-8-15-50(61)69-52/h8-10,14-18,21-22,30,34-42,44-47,51-52,57-59,62H,2,11-13,19-20,23-29H2,1,3-7H3,(H,55,60)/b14-9+,15-8-,17-16+,18-10+,31-21+,33-22+/t34-,35-,36+,37+,38+,39-,40+,41-,42+,44+,45+,46+,47+,51-,52-,53-/m0/s1
Standard InChI Key: OMDASWUIJVTXKG-CJNOQNAASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1044.09 | Molecular Weight (Monoisotopic): 1042.4402 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Uckun FM, Forsyth CJ.. (2001) Anticancer activity of synthetic analogues of the phorboxazoles., 11 (9): [PMID:11354372] [10.1016/s0960-894x(01)00191-3] |
Source(1):